Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
Covington
AstraZeneca
US Department of Justice
Merck

Generated: August 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALMOTRIPTAN MALATE

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for ALMOTRIPTAN MALATE

Trial ID Title Status Sponsor Phase Summary
NCT00210483 A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents Completed Ortho-McNeil Neurologics, Inc. Phase 3 The purpose of this study is to evaluate the effectiveness and safety of almotriptan malate (AXERT®) in treating acute migraine headaches in adolescents. Amotriptan malate (AXERT®) is approved for use in the treatment of acute migraine headache with or without aura in adults. In this study, adolescents will be given a single dose of study medication to treat one migraine headache.
NCT00210483 A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents Completed Janssen-Ortho LLC Phase 3 The purpose of this study is to evaluate the effectiveness and safety of almotriptan malate (AXERT®) in treating acute migraine headaches in adolescents. Amotriptan malate (AXERT®) is approved for use in the treatment of acute migraine headache with or without aura in adults. In this study, adolescents will be given a single dose of study medication to treat one migraine headache.
NCT00210496 Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 4 The purpose of this study is to evaluate the impact of topiramate (migraine prevention medicine) on the effectiveness of almotriptan malate (acute migraine medicine) when treating acute migraine headaches.
>Trial ID >Title >Status >Phase >Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for ALMOTRIPTAN MALATE

Condition Name

Condition Name for ALMOTRIPTAN MALATE
Intervention Trials
Migraine 5
Common Migraine 1
Classic Migraine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ALMOTRIPTAN MALATE
Intervention Trials
Migraine Disorders 5
Headache 1
Migraine without Aura 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ALMOTRIPTAN MALATE

Trials by Country

Trials by Country for ALMOTRIPTAN MALATE
Location Trials
United States 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ALMOTRIPTAN MALATE
Location Trials
Oklahoma 1
Florida 1
Tennessee 1
Texas 1
Utah 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ALMOTRIPTAN MALATE

Clinical Trial Phase

Clinical Trial Phase for ALMOTRIPTAN MALATE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ALMOTRIPTAN MALATE
Clinical Trial Phase Trials
Completed 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ALMOTRIPTAN MALATE

Sponsor Name

Sponsor Name for ALMOTRIPTAN MALATE
Sponsor Trials
Janssen-Ortho LLC 4
Ortho-McNeil Neurologics, Inc. 4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ALMOTRIPTAN MALATE
Sponsor Trials
Industry 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
Julphar
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.